Not applicableStudy completedNCT00166309What this trial is testingThe FEIBA NovoSeven Comparative StudyWho this might be right forSevere Hemophilia A With an Inhibitor Skane University Hospital 60
Large-scale testing (Phase 3)Looking for participantsNCT05145127What this trial is testingOpen-Label Extension Study of Marstacimab in Hemophilia Participants With or Without InhibitorsWho this might be right forHemophilia AHemophilia B Pfizer 245
Not applicableLooking for participantsNCT07096349What this trial is testingMultidimensional Assessment of Chronic Pain in Severe Haemophilia AWho this might be right forHemophilia A Without Inhibitor Investigación en Hemofilia y Fisioterapia 109
Not applicableStudy completedNCT04181697What this trial is testingHemFitBit, an Observational Study of Physical Activity in People With Moderate and Severe Haemophilia AWho this might be right forHemophilia A Without Inhibitor Oslo University Hospital 40
Large-scale testing (Phase 3)Study completedNCT03938792What this trial is testingStudy of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia BWho this might be right forHemophilia AHemophilia B Pfizer 189
Not applicableStudy completedNCT04165135What this trial is testingAn Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care TreatmentWho this might be right forSevere Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHaemophilia A Hoffmann-La Roche 103
Large-scale testing (Phase 3)Looking for participantsNCT05611801What this trial is testingA Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia BWho this might be right forHemophilia AHemophilia B Pfizer 100
Early research (Phase 1)WithdrawnNCT03996486What this trial is testingStudy to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe HemophiliaWho this might be right forHemophilia Bayer
Post-approval studies (Phase 4)Study completedNCT00284193What this trial is testingCombination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIIIWho this might be right forHemophilia A Sheba Medical Center 5